CoChat

Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults

Open access
Takala, Jukka, Ruokonen, Esko, Webster, Nigel R., Nielsen, Michael S., Zandstra, Durk F., Vundelinckx, Guy, Hinds, Charles J. · 1999 · New England Journal of Medicine

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The administration of growth hormone can attenuate the catabolic response to injury, surgery, and sepsis. However, the effect of high doses of growth hormone on the length of stay in intensive care and in the hospital, the duration of mechanical ventilation, and the outcome in critically ill adults who are hospitalized for long periods is not known. METHODS: We carried out two prospective, multicenter, double-blind, randomized, placebo-controlled trials in parallel involving 247 Finnish patients and 285 patients in other European countries who had been in an intensive care unit for 5 to 7 days and who were expected to require intensive care for at least 10 days. The patients had had cardiac surgery, abdominal surgery, multiple trauma, or acute respiratory failure. The patients received either growth hormone (mean [+/-SD] daily dose, 0.10 +/- 0.02 mg per kilogram of body weight) or placebo until discharge from intensive care or for a maximum of 21 days. RESULTS: The in-hospital mortality rate was higher in the patients who received growth hormone than in those who did not (P<0.001 for both studies). In the Finnish study, the mortality rate was 39 percent in the growth hormone group, as compared with 20 percent in the placebo group. The respective rates in the multinational study were 44 percent and 18 percent. The relative risk of death for patients receiving growth hormone was 1.9 (95 percent confidence interval, 1.3 to 2.9) in the Finnish study and 2.4 (95 percent confidence interval, 1.6 to 3.5) in the multinational study. Among the survivors, the length of stay in intensive care and in the hospital and the duration of mechanical ventilation were prolonged in the growth hormone group. CONCLUSIONS: In patients with prolonged critical illness, high doses of growth hormone are associated with increased morbidity and mortality.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm199909093411102

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Research works printed but not linked: 5

  1. 10.1210/jc.74.4.865 · doi:10.1210/jc.74.4.865
  2. Gatzen C, 1992, Surgery, 112, 181
  3. Jeevanandam M, 1994, Am J Physiol, 267, E560
  4. 10.1002/bjs.1800830214 · doi:10.1002/bjs.1800830214
  5. Tacke J, 1994, Infusionsther Transfusionsmed, 21, 24

Cited by

See all 1,023

Metadata

Authors
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J.
Affiliations
  • Kuopio University Hospital (FI)
  • Aberdeen Royal Infirmary (GB)
  • Southampton General Hospital (GB)
  • OLVG (NL)
  • St Bartholomew's Hospital (GB)
Venue
New England Journal of Medicine
Published
1999-09-09
Volume
341
Issue
11
Pages
785-792
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2325918023
Cited by
1,023
References
37
Citations by year
2026: 18 · 2025: 10 · 2024: 11 · 2023: 13 · 2022: 11 · 2021: 24 · 2020: 24 · 2019: 22 · 2018: 21 · 2017: 29 · 2016: 26 · 2015: 44 · 2014: 25 · 2013: 40 · 2012: 44
FWCI
37.71
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Keywords
growth hormone, critically ill adults, in-hospital mortality, ICU length of stay, mechanical ventilation duration, cardiac surgery, abdominal surgery, polytrauma, acute respiratory failure, adverse effects of growth hormone
MeSH terms
Adolescent, Adult, Aged, Energy Intake, Cause of Death, Critical Care, Double-Blind Method, Female, Humans, Insulin-Like Growth Factor I, Male, Middle Aged, Multiple Organ Failure, Prospective Studies, Risk, Shock, Septic, Critical Illness, Hospital Mortality, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults. https://app.cochat.ai/papers/10.1056/nejm199909093411102
The paper
Takala, J., Ruokonen, E., Webster, N. R., Nielsen, M. S., Zandstra, D. F., Vundelinckx, G., & Hinds, C. J. (1999). Increased Mortality Associated with Growth Hormone Treatment in Critically Ill Adults. New England Journal of Medicine. https://doi.org/10.1056/nejm199909093411102

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.